Secured a reversal of a more than $100 million verdict for a multinational pharmaceutical, medical device, and consumer goods company in a case in which the plaintiff alleged that he developed cancer after long-term exposure to asbestos in talcum powder-based products. The appellate court found that the testimony of two of the plaintiffs’ experts was improper and warranted a new trial.